Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Capital Financial Indonesia Tbk (CASA.JK)
Jakarta, ID
PT Capital Financial Indonesia Tbk, along with its group of subsidiaries, delivers a broad array of financial and investment offerings throughout Indonesia. Beyond these core services, the company's operations extend into numerous other fields, including commerce, manufacturing, building development, logistics, farming, publishing, automotive repair and maintenance, and general service provision, as well as the insurance sector. This enterprise, established in 2009, maintains its corporate base in Jakarta, Indonesia, and functions as a division of PT Capital Strategic Invesco.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.37% | +1.12% | -2.17% | +25.00% | -15.63% | +50.00% | +98.53% | +255.26% | +1,352.95% | +1,352.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Life: +10.6%-14.5% Q1'26: -20.9% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+17.7% ★ Q1'26: -33.3% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+3.3% Q1'26: +241.9% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+20.4% ★ Q1'26: +26.9% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+11.1% ★ Q1'26: -943.8% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×2.71× ★ Q1'26: 0.53× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 2/5 | 2/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Edhi Harpenta Sebayang | Head of Internal Audit | — | male |
| Maliana Herutama Malkan Msc. | President Director | — | — |
| Muhamad Aidil Fathany | Financial Director, Corporate Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CASA.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
